NCT00924560 - A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females | Biotech Hunter

Enrollment

1,361

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Bone Mineral Density

Interventions

DRUG

91-day Levonorgestrel Oral Contraceptive

"Levonorgestrel/ethinyl estradiol 0.15/0.03 mg and ethinyl estradiol 0.01 mg tablet.~Take 1 tablet daily"

DRUG

28-day Levonorgestrel Oral Contraceptive

Levonorgestrel/ethinyl estradiol 0.10/0.02 mg tablet and placebo. Take 1 tablet daily

Trial Locations (46)

Unknown

Teva Investigational Site 007, Phoenix

Teva Investigational Site 018, Phoenix

Teva Investigational Site 005, Tucson

Teva Investigational Site 047, North Little Rock

Teva Investigational Site 027, La Mesa

Teva Investigational Site 040, Los Angeles

Teva Investigational Site 037, Mountain View

Teva Investigational Site 013, San Diego

Teva Investigational Site 017, San Diego

Teva Investigational Site 025, Torrance

Teva Investigational Site 022, Washington D.C.

Teva Investigational Site 004, Boynton Beach

Teva Investigational Site 008, Clearwater

Teva Investigational Site 026, DeLand

Teva Investigational Site 001, Miami

Teva Investigational Site 003, Miami

Teva Investigational Site 028, Tampa

Teva Investigational Site 041, West Palm Beach

Teva Investigational Site 034, Champaign

Teva Investigational Site 023, Louisville

Teva Investigational Site 021, Baton Rouge

Teva Investigational Site 030, St Louis

Teva Investigational Site 009, Lincoln

Teva Investigational Site 010, Lawrenceville

Teva Investigational Site 038, Port Jefferson

Teva Investigational Site 048, Rochester

Teva Investigational Site 002, Durham

Teva Investigational Site 043, Kernersville

Teva Investigational Site 044, New Bern

Teva Investigational Site 020, Raleigh

Teva Investigational Site 006, Winston-Salem

Teva Investigational Site 033, Cleveland

Teva Investigational Site 012, Medford

Teva Investigational Site 035, Pittsburgh

Teva Investigational Site 039, Pottstown

Teva Investigational Site 036, Providence

Teva Investigational Site 032, Charleston

Teva Investigational Site 024, Columbia

Teva Investigational Site 046, Dallas

Teva Investigational Site 031, Houston

Teva Investigational Site 045, Houston

Teva Investigational Site 011, Waco

Teva Investigational Site 015, Salt Lake City

Teva Investigational Site 019, Norfolk

Teva Investigational Site 014, Seattle

Teva Investigational Site 016, Spokane